REPLIGEN CORP Assets, Noncurrent
REPLIGEN CORP (RGEN) had Assets, Noncurrent of $1.81 billion as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2026-02-26
- 2025-12-31: Assets, Noncurrent $1.81B.
- 2025-09-30: Assets, Noncurrent $1.83B.
- 2025-06-30: Assets, Noncurrent $1.84B.
- 2025-03-31: Assets, Noncurrent $1.82B.
| Period end | Assets, Noncurrent | Assets, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $1.81B 10-K · filed 2026-02-26 | |
| 2025-09-30 | $1.83B 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $1.84B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.82B 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $1.76B 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.70B 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $1.71B 10-Q/A · filed 2024-11-18 | $1.70B 10-Q · filed 2024-07-30 |
| 2024-03-31 | $1.72B 10-Q/A · filed 2024-11-18 | $1.72B 10-Q · filed 2024-05-01 |
| 2023-12-31 | $1.72B 10-K · filed 2025-03-14 | $1.71B 10-K · filed 2024-02-22 |
| 2023-09-30 | $1.54B 10-Q/A · filed 2024-11-18 | $1.54B 10-Q · filed 2023-10-31 |
| 2023-06-30 | $1.56B 10-Q/A · filed 2024-11-18 | $1.55B 10-Q · filed 2023-08-02 |
| 2023-03-31 | $1.53B 10-Q/A · filed 2024-11-18 | $1.52B 10-Q · filed 2023-05-02 |
| 2022-12-31 | $1.53B 10-Q/A · filed 2024-11-18 | $1.53B 10-K · filed 2023-02-22 |
| 2022-09-30 | $1.51B 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $1.47B 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $1.44B 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $1.43B 10-K · filed 2023-02-22 | |
| 2021-09-30 | $1.33B 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $1.03B 10-Q · filed 2021-07-27 | |
| 2021-03-31 | $1.00B 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $1.00B 10-K · filed 2022-02-17 | |
| 2017-12-31 | $500.74M 10-K · filed 2018-02-22 | |
| 2016-12-31 | $104.76M 10-K · filed 2018-02-22 | |
| 2015-12-31 | $42.98M 10-K · filed 2017-02-23 | |
| 2014-12-31 | $47.35M 10-K · filed 2016-02-25 | $47.35M 10-K · filed 2015-03-17 |
| 2013-12-31 | $32.29M 10-K · filed 2015-03-17 | |
| 2012-12-31 | $30.80M 10-K · filed 2014-03-14 | |
| 2011-12-31 | $29.16M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |